PDP1 and Sepsis: Based on our data and the data from previous studies, we speculate that inhibition of PDK may promote PDH activity and pyruvate-driven oxidative phosphorylation, improve mitochondrial bioenergetic in septic heart, and thus represent a novel therapeutic approach for sepsis-induced cardiomyopathy.